NVCR - NovoCure Limited's (NVCR) CEO Asaf Danziger on Q1 2021 Results - Earnings Call Transcript

NovoCure Limited (NVCR) Q1 2021 Earnings Conference Call April 29, 2021, 08:00 AM ET Company Participants Adam Daney - Investor Relations William Doyle - Executive Chairman Asaf Danziger - Chief Executive Officer Ashley Cordova - Chief Financial Officer Uri Weinberg - Chief Science Officer Pritesh Shah - Chief Commercial Officer Conference Call Participants Jason Bednar - Piper Sandler Vijay Kumar - Evercore ISI Daniel Clark - Mizuho Larry Biegelsen - Wells Fargo Cory Kasimov - JP Morgan Jason Wittes - Northland Capital Markets Presentation Operator Good day and thank you for standing by. Welcome to the NovoCure’s First Quarter 2021 Earnings Conference. At this time, all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions] I would now like to hand the conference over to your speaker today, Adam Daney. Adam Daney Good morning everyone and thank you for joining us

For further details see:

NovoCure Limited's (NVCR) CEO Asaf Danziger on Q1 2021 Results - Earnings Call Transcript